| Carrie Lynn Malfatto, CRNA, MSN | |
|
7333 Smiths Mill Rd, New Albany, OH 43054-9291 | |
| (614) 775-6340 | |
| Not Available |
| Full Name | Carrie Lynn Malfatto |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 7333 Smiths Mill Rd, New Albany, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174558167 | NPI | - | NPPES |
| 2643803 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | CO 08546; RN 300270 (Ohio) | Primary |
| Entity Name | Osu Health System Anesthesia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174581185 PECOS PAC ID: 8426959214 Enrollment ID: O20040115000490 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced it will be meeting with several U.S. investment bankers, analysts and fund managers during J.P. Morgan's 29th annual Healthcare Conference held from January 10th to January 13th, 2011, in San Francisco, California.
New research from the University of Michigan Comprehensive Cancer Center helps explain why pancreatic cancer is so lethal, with fewer than a third of patients surviving even early stage disease.
Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules.
Sorin Group: Consolidated results for second quarter 2011: Revenues of €191.9 million, a 0.6% increase over the same period last year.
How can we detect cancer and viruses with high sensitivity? Physical chemist Laura Fabris-;an associate professor in the Materials Science and Engineering Department at Rutgers, the State University of New Jersey, and principal investigator of the Fabris NanoBio Group-;is addressing this very question.
› Verified 9 days ago
| Entity Name | Osu Observation Medicine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407095052 PECOS PAC ID: 3375692270 Enrollment ID: O20090526000354 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced it will be meeting with several U.S. investment bankers, analysts and fund managers during J.P. Morgan's 29th annual Healthcare Conference held from January 10th to January 13th, 2011, in San Francisco, California.
New research from the University of Michigan Comprehensive Cancer Center helps explain why pancreatic cancer is so lethal, with fewer than a third of patients surviving even early stage disease.
Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules.
Sorin Group: Consolidated results for second quarter 2011: Revenues of €191.9 million, a 0.6% increase over the same period last year.
How can we detect cancer and viruses with high sensitivity? Physical chemist Laura Fabris-;an associate professor in the Materials Science and Engineering Department at Rutgers, the State University of New Jersey, and principal investigator of the Fabris NanoBio Group-;is addressing this very question.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carrie Lynn Malfatto, CRNA, MSN 5505 River Forest Rd, Dublin, OH 43017-8696 Ph: (216) 337-4723 | Carrie Lynn Malfatto, CRNA, MSN 7333 Smiths Mill Rd, New Albany, OH 43054-9291 Ph: (614) 775-6340 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced it will be meeting with several U.S. investment bankers, analysts and fund managers during J.P. Morgan's 29th annual Healthcare Conference held from January 10th to January 13th, 2011, in San Francisco, California.
New research from the University of Michigan Comprehensive Cancer Center helps explain why pancreatic cancer is so lethal, with fewer than a third of patients surviving even early stage disease.
Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules.
Sorin Group: Consolidated results for second quarter 2011: Revenues of €191.9 million, a 0.6% increase over the same period last year.
How can we detect cancer and viruses with high sensitivity? Physical chemist Laura Fabris-;an associate professor in the Materials Science and Engineering Department at Rutgers, the State University of New Jersey, and principal investigator of the Fabris NanoBio Group-;is addressing this very question.
› Verified 9 days ago
Robin Lee Kubasek, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6520 W Campus Oval, New Albany, OH 43054 Phone: 614-413-2233 | |
Mr. Jack Robert Fry, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7333 Smiths Mill Rd, New Albany, OH 43054 Phone: 614-775-6675 | |
Cynthia D. Fisher, C.R.N.A. Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 6520 West Campus Oval, Central Ohio Surgical Institute, New Albany, OH 43054 Phone: 614-413-2233 Fax: 614-413-2234 | |
Robert Tyler Fisher, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 5031 Forest Dr Ste C, New Albany, OH 43054 Phone: 614-939-5416 | |
Patricia White, C.R.N.A. Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: Central Ohio Surgical Institute, 6520 West Campus Oval, New Albany, OH 43054 Phone: 614-413-2233 Fax: 614-413-2234 | |
Karen M. Rice, C.R.N.A. Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: Central Ohio Surgical Institute, 6520 West Campus Oval, New Albany, OH 43054 Phone: 614-413-2233 Fax: 614-413-2234 |